Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC

Not yet recruiting

• Conditions: Surgical Procedure, Unspecified; Intensive Care Units (ICUs)

• Registration Number: NCT06638073
• Lead Sponsor: Medtronic - MITG

Brief Summary

To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - in hospital and at-home, in patients undergoing non-cardiac surgery.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-09
• Study First Submitted: 2024-09-16
• Study First Submitted QC: 2024-10-09
• Study First Posted: 2024-10-15
• Last Update Submitted: 2024-12-04
• Last Update Posted: 2024-12-05
• Study Start: 2025-01-20
• Primary Completion: 2025-03-20
• Study Completion: 2025-03-20

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• 19 years or older
• Patients that have undergone a non-cardiac surgery at SPH requiring an inpatient hospital stay
• Peri-op patients who are in the Surgical High Acuity Unit (SHAU) and those followed by Anesthesia Perioperative Outreach team on the ward
• Living within British Columbia, Canada and in an area that is covered by Bell cellular network

Read More

Exclusion Criteria

• Patient refusal
• Lack of capacity to consent to the study (including having received sedative or general anesthetic within the past 24 hours)
• Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
• Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
• No access to cell phone nor landline at home to receive follow-ups
• Preoperatively known to be discharged to a nursing home or rehabilitation facility
• Known allergic reactions to any part material of study devices

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Collect patient and clinicians' feedback about the CCPC Platform	From enrollment to the end of follow up at 10 days	This will be completed by an evaluation of potential harm, adverse events and safety issues.
Confirm the technical goals of the CCPC platform are met.	From enrollment to the end of follow up at 10 days	This will be completed by determining if the CCPC platform provided a holistic view of each patient with vitals, medication, and other collected data.

Trial Locations

Locations (1)

Saint Pauls Hospital; 🇨🇦 Vancouver, British Columbia, Canada